Dapagliflozin attenuates progression from prefrailty to frailty in patients with hypertension and chronic kidney disease

Coverage, in order

1. 4d ago
   JCI indie study

   Dapagliflozin attenuates progression from prefrailty to frailty in patients with hypertension and chronic kidney disease

   BACKGROUND Chronic kidney disease (CKD) and hypertension share common pathophysiological pathways contributing to vascular damage, endothelial dysfunction, and physical decline, particularly in older adults with prefrailty. To evaluate the relationship among renal injury, physical performance, and…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.